Grifols Update Regarding COVID-19
As the situation with the novel coronavirus rapidly evolves, we wanted to inform you that Grifols is taking measures in line with recommendations from the …
Read MoreNews
European Lung Foundation Offers Grants for Healthy Lungs for Life Events
In 2020, the European Lung Foundation (ELF) will open two rounds of grants applications. Each round will offer five grants of €1,000 to the applicants …
Read More
2019 Novel Coronavirus (2019-nCoV) and Plasma Protein Therapies
Recent international reports have highlighted the emergence of a new coronavirus in Wuhan, Hubei Province, China. The 2019 Novel Coronavirus (2019-nCoV) was first identified by …
Read More
Alpha-1 Global Reveals 2020 Global Hub Centers
Alpha-1 Global is proud to announce that three Alpha-1 patient organisations have been selected as Alpha-1 Global Hub Centers. The Alpha-1 Foundation Ireland, Fundación Argentina …
Read More
Grifols’s Prolastina Approved for Use in Denmark
The Alpha-1 Foundation is proud to report that multinational pharmaceutical manufacturer Grifols has received approval for reimbursement by the Danish Medicines Council for Prolastina, a …
Read More
Danish Medicines Council Grants Approval for CSL Behring’s Respreeza as Standard Treatment for Severe Alpha-1 Antitrypsin Deficiency Patients
HATTERSHEIM AM MAIN, Germany, Jan. 24, 2020 – Global biopharmaceutical company CSL Behring announced that the Danish Medicines Council has published its final decision regarding …
Read More
European Lung Foundation Conducts Alpha-1 Survey to Establish Future Research Priorities
The European Lung Foundation (ELF) is asking members of the Alpha-1 community for their help in identifying the challenges of care, treatment and living with …
Read More
Alpha-1 Global Announces Launch of Alpha-1 Global Hub Centers
Alpha-1 Global is launching a program called the Alpha-1 Global Hub Centers. The goal of the program is to create 5-6 centers globally that will …
Read More
CSL Behring Announces Grant for EU Advocacy Development
Dear EU Alpha-1 Global Partners: We are pleased to provide you information regarding CSL Behring’s announcement for Local Empowerment for Advocacy Development (LEAD) Grants available …
Read More
CSL Behring announcement on their product Zemaira
Today, the Alpha-1 Foundation received the following communication from CSL Behring, regarding Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin …
Read More